ArticleCureus2025
Beyond the Blot: Diagnostic Challenges in Atypical Dermatomyositis With Overlapping Myasthenia Gravis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatomyositis (DM) is a rare autoimmune inflammatory myopathy characterized by both cutaneous and muscular involvement, often associated with specific autoantibodies and systemic manifestations. This case report presents a young male patient in the United Kingdom with DM, who had a negative myositis blot, panel of autoantibodies, and also had features of myasthenia gravis (MG). Despite trials of multiple immunosuppressive therapies, severe dysphagia persisted. This case underscores the diagnostic complexity of autoimmune neuromuscular disorders and the importance of early consideration of overlap syndromes when clinical features deviate from the classical DM phenotype and bulbar involvement is present. In a healthcare setting where patients may present with diverse and complex autoimmune profiles, this case highlights the need for vigilance and early recognition of rare overlaps such as DM and MG, which is crucial for optimizing patient care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.